form8k.htm
As Filed
with the Securities and Exchange Commission on January 6, 2010
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
_________________________________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): January 6,
2010
MONSANTO
COMPANY
(Exact
Name of Registrant as Specified in its Charter)
|
Delaware
|
001-16167
|
43-1878297
|
|
State
of Incorporation
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
800
North Lindbergh Boulevard
St.
Louis, Missouri 63167
(Address of Principal Executive
Offices) (Zip Code)
Registrant's
telephone number, including area code: (314) 694-1000
Not
Applicable
(Former
Name or Former Address, If Changed Since Last Report)
_________________________________
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligations under any of the following provisions (see
General Instruction A.2. below):
|
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
ITEM
2.02. Results of Operations and Financial Condition.
On
January 6, 2010, Monsanto Company issued a press release announcing its first
quarter fiscal year 2010 financial and operating results for the period ended
November 30, 2009. This press release is furnished as Exhibit 99 hereto and
incorporated herein by reference.
The press
release furnished herewith uses the non-GAAP financial measure of earnings per
share (“EPS”) on an ongoing basis. Our ongoing EPS financial measure
excludes certain after-tax items that we do not consider part of ongoing
operations. We believe that our ongoing EPS financial measure
presented with these adjustments best reflects our ongoing performance and
business operations during the periods presented and is more useful to investors
for comparative purposes. In addition, management uses the ongoing
EPS financial measure as a guide in its budgeting and long-range planning
processes, and as a guide in determining incentive compensation. The
presentation of EPS on an ongoing basis is intended to supplement investors’
understanding of our operating performance. This non-GAAP financial
measure may not be comparable to similar measures used by other
companies. Information concerning Monsanto’s use of the non-GAAP
financial measures free cash flow and EBIT appears in Monsanto’s most recent
Report on Form 10-K.
We are
furnishing the information contained in this report, including the Exhibit,
pursuant to “Item 2.02 Results of Operations and Financial Condition” of Form
8-K promulgated by the SEC. This information shall not be deemed to
be “filed” for the purposes of Section 18 of the Exchange Act or otherwise
subject to the liabilities of that section, unless we specifically incorporate
it by reference in a document filed under the Securities Act or the Exchange
Act. By filing this report on Form 8-K and furnishing this
information, we make no admission as to the materiality of any information in
this report, including the Exhibit.
ITEM
9.01. FINANCIAL
STATEMENTS AND EXHIBITS.
(d) Exhibits
The
following exhibit is filed herewith:
Exhibit
99 Press
Release, dated January 6, 2010, issued by Monsanto Company
_________________________________
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: January
6, 2010
|
|
MONSANTO
COMPANY
|
|
|
|
|
|
|
|
|
By: /s/ Christopher A.
Martin
|
|
|
Name: Christopher
A. Martin
|
|
|
Title: Assistant
Secretary
|
EXHIBIT
INDEX
|
Exhibit No.
|
|
Description of Exhibit
|
|
|
|
|
|
99
|
|
Press
Release, dated January 6, 2010, issued by Monsanto
Company
|